Clinical Efficacy and Mechanism of Danggui Liuhuang Tang in Reducing Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus with Yin Deficiency and Fire Excess Syndrome
|更新时间:2025-07-01
|
Clinical Efficacy and Mechanism of Danggui Liuhuang Tang in Reducing Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus with Yin Deficiency and Fire Excess Syndrome
增强出版
“The latest research found that Danggui Liuhuang Decoction can effectively reduce the cardiovascular risk of type 2 diabetes patients, and its mechanism may play an anti-inflammatory effect by inhibiting MyD88/NF - κ B signaling pathway.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 15, Pages: 163-172(2025)
XU Yuanying,YU Shanshan,JIN Xinyan,et al.Clinical Efficacy and Mechanism of Danggui Liuhuang Tang in Reducing Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus with Yin Deficiency and Fire Excess Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(15):163-172.
XU Yuanying,YU Shanshan,JIN Xinyan,et al.Clinical Efficacy and Mechanism of Danggui Liuhuang Tang in Reducing Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus with Yin Deficiency and Fire Excess Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(15):163-172. DOI: 10.13422/j.cnki.syfjx.20250122.
Clinical Efficacy and Mechanism of Danggui Liuhuang Tang in Reducing Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus with Yin Deficiency and Fire Excess Syndrome增强出版
Mechanism of Huangqi Gegen Decoction in Treatment of Type 2 Diabetes Mellitus via Intestinal Mucosal Barrier
Danggui Shaoyaosan Combined with Yinchenhaotang Regulates Lipid Metabolism to Ameliorate Type 2 Diabetes Mellitus Complicated with Metabolic Dysfunction-associated Steatotic Liver Disease
Application ofPuerariae Lobatae Radixin Treatment of Type 2 Diabetes Mellitus: A Review
Modified Buwangsan Ameliorates Cognitive Dysfunction in Rat Model of Type 2 Diabetes Mellitus by Regulating Autophagy in Hippocampus via PI3K/Akt/mTOR Pathway
Related Author
PENG Lili
HAO Miao
YANG Zhijun
LIU Yajie
YUAN Hongxia
XU Yilin
LI Liu
ZOU Junju
Related Institution
Shanxi Key Laboratory of Innovative Drug for Treatment of Serious Diseases Basing on Chronic Inflammation,College of Traditional Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine
Hunan University of Chinese Medicine
Key Laboratory of Modern Chinese Medicine Formulations of Jiangxi University of Chinese Medicine, Ministry of Education
School of Pharmacy,Jiangxi University of Chinese Medicine
National Key Laboratory of Creation of Modern Chinese Medicine with Classical Formulas